Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Bone metastases (BMs) occur commonly in patients with metastatic renal cell carcinoma (mRCC). Tyrosine kinase inhibitors (TKIs) have improved the outcomes for patients with mRCC. However, data on the outcomes of mRCC patients with BMs treated with TKIs are limited. We describe the outcomes of patients with BMs treated with TKI therapy and compare them with the outcomes from a pre-TKI group.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Genitourin Cancer

Title: Clinical genitourinary cancer

Publisher: Elsevier BV

ISSN (Electronic): 1938-0682

ISSN (Print): 1558-7673

Publication date (Electronic): Jun 2017

Volume: 15

Issue: 3

Affiliations

[1 ] Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Emergency Medicine, Baylor College of Medicine, Houston, TX.

[2 ] Department of Radiation Oncology, University of Miami, Miami, FL.

[3 ] Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

[4 ] Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.

[5 ] Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

[6 ] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

[7 ] Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ejonasch@mdanderson.org.

Article

Publisher Item ID: S1558-7673(17)30010-1

DOI: 10.1016/j.clgc.2017.01.010

PubMed ID: 28216278

SO-VID: ceff966c-9365-4a69-bd80-56b912adc31b

History

Keywords: BM,Kidney,RCC,TKI,Zoledronic acid

Data availability:

Keywords: BM, Kidney, RCC, TKI, Zoledronic acid

Comments

Comment on this article

scite_

Cited by 6

See all cited by